Published in J Clin Epidemiol on August 03, 2007
The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol (2010) 4.10
The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 3.24
Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. BMJ (2009) 2.57
Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol (2010) 2.28
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19
The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol (2009) 1.73
Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg (2010) 1.63
Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med (2009) 1.62
Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes. Qual Life Res (2010) 1.61
Comparative responsiveness and minimal clinically important differences for idiopathic ulnar impaction syndrome. Clin Orthop Relat Res (2013) 1.56
Minimally important difference for the Expanded Prostate Cancer Index Composite Short Form. Urology (2015) 1.48
Improved responsiveness and reduced sample size requirements of PROMIS physical function scales with item response theory. Arthritis Res Ther (2011) 1.44
Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation. J Gerontol A Biol Sci Med Sci (2011) 1.43
Validation and psychometric properties of the Asthma Control Questionnaire among children. J Allergy Clin Immunol (2013) 1.40
A Double-Blinded Randomized Trial to Compare the Effectiveness of Minimally Invasive Procedures Using Patient-Reported Outcomes. J Am Coll Surg (2015) 1.39
Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test. Crit Care Med (2016) 1.37
The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice. J Rheumatol (2008) 1.29
Development and psychometric properties of the PROMIS(®) pediatric fatigue item banks. Qual Life Res (2013) 1.27
Comparative responsiveness of pain outcome measures among primary care patients with musculoskeletal pain. Med Care (2010) 1.20
Minimal clinically important improvement (MCII) and patient-acceptable symptom state (PASS) in total hip arthroplasty (THA) patients 1 year postoperatively. Acta Orthop (2013) 1.18
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer (2010) 1.15
Minimal clinically important differences in health-related quality of life after total hip or knee replacement: A systematic review. Bone Joint Res (2012) 1.14
Responsiveness and minimal important differences after revision total hip arthroplasty. BMC Musculoskelet Disord (2010) 1.14
Meaningful changes for the Oxford hip and knee scores after joint replacement surgery. J Clin Epidemiol (2014) 1.10
Patient-reported outcome measures suitable to assessment of patient navigation. Cancer (2011) 1.09
Minimal Important Difference (MID) of two commonly used outcome measures for foot problems. J Foot Ankle Res (2010) 1.07
Sensitivity to change and responsiveness of four balance measures for community-dwelling older adults. Phys Ther (2011) 1.05
Psychosocial outcomes of three triage methods for the management of borderline abnormal cervical smears: an open randomised trial. BMJ (2010) 1.03
Minimal important differences of the SRS-22 Patient Questionnaire following surgical treatment of idiopathic scoliosis. Eur Spine J (2009) 1.03
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys (2010) 1.02
Linking the Tinnitus Questionnaire and the subjective Clinical Global Impression: which differences are clinically important? Health Qual Life Outcomes (2012) 1.01
The questionnaire for urinary incontinence diagnosis (QUID): validity and responsiveness to change in women undergoing non-surgical therapies for treatment of stress predominant urinary incontinence. Neurourol Urodyn (2010) 1.01
Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insights (2013) 1.01
Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT). Health Qual Life Outcomes (2013) 1.00
Impact of clinical and patient-reported outcomes on patient satisfaction with cataract extraction. Health Expect (2012) 0.99
Patient acceptable symptom states after totalhip or knee replacement at mid-term follow-up: Thresholds of the Oxford hip and knee scores. Bone Joint Res (2014) 0.98
The Minimum Clinically Important Difference of the Patient-rated Wrist Evaluation Score for Patients With Distal Radius Fractures. Clin Orthop Relat Res (2015) 0.98
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study. Rheumatology (Oxford) (2009) 0.97
Agreement about identifying patients who change over time: cautionary results in cataract and heart failure patients. Med Decis Making (2011) 0.97
IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Clin Trials (2013) 0.96
Psychometric properties of the Brief Pain Inventory among patients with osteoarthritis undergoing total hip replacement surgery. Health Qual Life Outcomes (2010) 0.95
Responsiveness and interpretability of incontinence severity scores and FIQL in patients with fecal incontinence: a secondary analysis from a randomized controlled trial. Int Urogynecol J (2012) 0.94
Interpreting and evaluating the CASP-19 quality of life measure in older people. Age Ageing (2012) 0.94
PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions. J Clin Epidemiol (2016) 0.94
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes (2009) 0.94
The responsiveness of sensibility and strength tests in patients undergoing carpal tunnel decompression. BMC Musculoskelet Disord (2011) 0.94
Triangulating Clinically Meaningful Change in the Six-minute Walk Test in Individuals with Chronic Heart Failure: A Systematic Review. Cardiopulm Phys Ther J (2012) 0.92
The king's foot of patient-reported outcomes: current practices and new developments for the measurement of change. Qual Life Res (2011) 0.92
Responsiveness of the Oswestry Disability Index and the Roland Morris Disability Questionnaire in Italian subjects with sub-acute and chronic low back pain. Eur Spine J (2011) 0.92
Health-related quality of life as an outcome variable in Parkinson's disease. Ther Adv Neurol Disord (2012) 0.92
Estimating minimally important difference (MID) in PROMIS pediatric measures using the scale-judgment method. Qual Life Res (2015) 0.92
Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences. Qual Life Res (2013) 0.92
Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis. Arthritis Res Ther (2009) 0.91
The minimum important difference for the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire. Int Urogynecol J (2014) 0.90
Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: results from a randomized, controlled Phase III study. Health Qual Life Outcomes (2008) 0.90
Determination and comparison of the smallest detectable change (SDC) and the minimal important change (MIC) of four-shoulder patient-reported outcome measures (PROMs). J Orthop Surg Res (2013) 0.90
Responsiveness to change for the Brazilian Scale of Oral Health Outcomes for 5-year-old children (SOHO-5). Health Qual Life Outcomes (2013) 0.90
Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients. Arthritis Care Res (Hoboken) (2015) 0.89
Life-space mobility assessment in older people in Finland; measurement properties in winter and spring. BMC Res Notes (2014) 0.88
Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment. Health Qual Life Outcomes (2009) 0.88
Minimum important differences for scales assessing symptom severity and quality of life in patients with fecal incontinence. Female Pelvic Med Reconstr Surg (2014) 0.88
Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors. Health Serv Res (2012) 0.88
Assessing the stroke-specific quality of life for outcome measurement in stroke rehabilitation: minimal detectable change and clinically important difference. Health Qual Life Outcomes (2011) 0.87
A prospective study of the association of patient expectations with changes in health-related quality of life outcomes, following total joint replacement. BMC Musculoskelet Disord (2014) 0.87
Modifying measures based on differential item functioning (DIF) impact analyses. J Aging Health (2012) 0.87
Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical Implication. Breast Care (Basel) (2009) 0.87
The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition. Qual Life Res (2012) 0.87
Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure. Chest (2015) 0.86
Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford) (2011) 0.86
The minimally important difference and patient acceptable symptom state for the Raynaud's condition score in patients with Raynaud's phenomenon in a large randomised controlled clinical trial. Ann Rheum Dis (2009) 0.86
Timed Up & Go as a measure for longitudinal change in mobility after stroke - Postural Stroke Study in Gothenburg (POSTGOT). J Neuroeng Rehabil (2014) 0.86
Clinical pressure pain threshold testing in neck pain: comparing protocols, responsiveness, and association with psychological variables. Phys Ther (2014) 0.86
Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study. Osteoarthritis Cartilage (2014) 0.86
Patient Reported Outcome (PRO) assessment in epilepsy: a review of epilepsy-specific PROs according to the Food and Drug Administration (FDA) regulatory requirements. Health Qual Life Outcomes (2013) 0.85
Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial. Osteoporos Int (2011) 0.85
The minimum important difference for the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form in women with stress urinary incontinence. Neurourol Urodyn (2013) 0.85
Data collection challenges in community settings: insights from two field studies of patients with chronic disease. Qual Life Res (2014) 0.84
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. J Rheumatol (2011) 0.84
Reliability, validity and responsiveness of the cross-culturally adapted Italian version of the core outcome measures index (COMI) for the neck. Eur Spine J (2013) 0.83
Determinants of agreement between self-reported and parent-assessed quality of life for children in Germany-results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Health Qual Life Outcomes (2011) 0.83
Psychometric evaluation of the Care Transition Measure in TRACE-CORE: do we need a better measure? J Am Heart Assoc (2014) 0.83
Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence (2014) 0.83
Measuring pediatric patient-reported outcomes: good progress but a long way to go. Qual Life Res (2014) 0.83
Study protocol of effectiveness of a biopsychosocial multidisciplinary intervention in the evolution of non-specific sub-acute low back pain in the working population: cluster randomised trial. BMC Health Serv Res (2010) 0.83
An overview of children's oral health-related quality of life assessment: from scale development to measuring outcomes. Caries Res (2013) 0.83
Hyperacusis Questionnaire as a Tool for Measuring Hypersensitivity to Sound in a Tinnitus Research Population. Biomed Res Int (2015) 0.82
Assessment of the impact of treatment on quality of life of patients with haemophilia A at different ages: insights from two clinical trials on turoctocog alfa. Haemophilia (2014) 0.82
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Support Care Cancer (2012) 0.82
Comparison of the responsiveness of the foot health status questionnaire and the Manchester foot pain and disability index in older people. Health Qual Life Outcomes (2014) 0.82
Longitudinal comparison of three depression measures in adult cancer patients. J Pain Symptom Manage (2012) 0.82
Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q). BMC Med Res Methodol (2011) 0.82
Checklist to operationalize measurement characteristics of patient-reported outcome measures. Syst Rev (2016) 0.81
Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions. PLoS One (2015) 0.81
Performance of an item response theory-based computer adaptive test in identifying functional decline. Arch Phys Med Rehabil (2012) 0.81
A longitudinal assessment of the responsiveness of the ICECAP-A in a randomised controlled trial of a knee pain intervention. Qual Life Res (2015) 0.81
The minimal clinically important difference for Knee Society Clinical Rating System after total knee arthroplasty for primary osteoarthritis. Knee Surg Sports Traumatol Arthrosc (2016) 0.81
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care (2007) 12.71
Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial. Lancet (2011) 12.13
Pazopanib versus sunitinib in metastatic renal-cell carcinoma. N Engl J Med (2013) 10.74
Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med (2012) 10.10
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain (2007) 8.89
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study. J Clin Oncol (2014) 6.64
Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp). Ann Behav Med (2002) 5.69
The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes (2003) 5.58
Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol (2011) 5.43
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol (2002) 4.69
The role of the bifactor model in resolving dimensionality issues in health outcomes measures. Qual Life Res (2007) 4.61
A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med (2002) 4.49
Relationship between burnout and professional conduct and attitudes among US medical students. JAMA (2010) 4.34
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet (2006) 4.26
Psychometric properties of the Consumer Assessment of Health Plans Study (CAHPS) 2.0 adult core survey. Health Serv Res (2003) 4.24
Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger. Assessment (2011) 4.21
Race/ethnicity, language, and patients' assessments of care in Medicaid managed care. Health Serv Res (2003) 4.19
Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel. J Clin Epidemiol (2010) 4.18
Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy-hepatobiliary questionnaire. J Clin Oncol (2002) 4.16
Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items. Qual Life Res (2009) 4.13
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report. Value Health (2008) 3.68
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes (2007) 3.66
Prospective, observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung, or prostate cancer. J Clin Oncol (2012) 3.65
Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma. J Clin Oncol (2012) 3.65
Randomized phase II trial of first-line treatment with sorafenib versus interferon Alfa-2a in patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 3.65
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol (2004) 3.57
US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med Care (2007) 3.56
Special report: suicidal ideation among American surgeons. Arch Surg (2011) 3.53
Prevalence of alcohol use disorders among American surgeons. Arch Surg (2012) 3.53
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial. J Clin Oncol (2013) 3.48
Burnout and medical errors among American surgeons. Ann Surg (2010) 3.44
A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof (2005) 3.43
Physician communication when prescribing new medications. Arch Intern Med (2006) 3.27
Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc (2002) 3.26
Assessment of neurological and behavioural function: the NIH Toolbox. Lancet Neurol (2010) 3.20
Item response theory analyses of physical functioning items in the medical outcomes study. Med Care (2007) 3.10
Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol (2005) 2.98
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. J Clin Oncol (2007) 2.97
Burnout and career satisfaction among American surgeons. Ann Surg (2009) 2.87
Development of a PROMIS item bank to measure pain interference. Pain (2010) 2.85
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.82
Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. J Clin Oncol (2012) 2.82
Patients' global ratings of their health care are not associated with the technical quality of their care. Ann Intern Med (2006) 2.68
Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr (2006) 2.65
Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer. J Clin Oncol (2005) 2.65
Half standard deviation estimate of the minimally important difference in HRQOL scores? Expert Rev Pharmacoecon Outcomes Res (2004) 2.58
Estimating clinically significant differences in quality of life outcomes. Qual Life Res (2005) 2.55
Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res (2009) 2.55
General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof (2005) 2.51
Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol (2007) 2.50
Patterns of unit and item nonresponse in the CAHPS Hospital Survey. Health Serv Res (2005) 2.49
Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes (2006) 2.48
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain (2007) 2.47
Burnout among U.S. medical students, residents, and early career physicians relative to the general U.S. population. Acad Med (2014) 2.47
Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group. J Clin Oncol (2003) 2.41
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing. J Rheumatol (2009) 2.39
Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav (2008) 2.39
Linguistic disparities in health care access and health status among older adults. J Gen Intern Med (2006) 2.35
Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol (2008) 2.34
Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes (2007) 2.34
Patient engagement in research: a systematic review. BMC Health Serv Res (2014) 2.33
Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res (2003) 2.32
Are inflammatory cytokines the common link between cancer-associated cachexia and depression? J Support Oncol (2005) 2.27
Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients. J Clin Epidemiol (2011) 2.24
Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D. Med Care (2007) 2.22
Methodological challenges associated with patient responses to follow-up longitudinal surveys regarding quality of care. Health Serv Res (2003) 2.21
Cancer, comorbidities, and health-related quality of life of older adults. Health Care Financ Rev (2008) 2.20
Impact of cancer on health-related quality of life of older Americans. J Natl Cancer Inst (2009) 2.20
Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst (2002) 2.19
Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol (2010) 2.19
Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy. Cancer (2002) 2.17
Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol (2011) 2.16
Exploratory factor analyses of the CAHPS Hospital Pilot Survey responses across and within medical, surgical, and obstetric services. Health Serv Res (2005) 2.15
A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol (2004) 2.14
Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample. Qual Life Res (2009) 2.10
Psychometric properties of a group-level Consumer Assessment of Health Plans Study (CAHPS) instrument. Med Care (2005) 2.09
Quality of life of patients with endometrial cancer undergoing laparoscopic international federation of gynecology and obstetrics staging compared with laparotomy: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.08
Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology (2005) 2.07
What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health (2007) 2.06
Effect of a multidisciplinary intervention on communication and collaboration among physicians and nurses. Am J Crit Care (2005) 2.06
Severity of visual field loss and health-related quality of life. Am J Ophthalmol (2007) 2.05
Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study. Clin Infect Dis (2003) 2.05
Patients' preferences for technical versus interpersonal quality when selecting a primary care physician. Health Serv Res (2005) 2.01
Mode of administration is important in US national estimates of health-related quality of life. Med Care (2007) 2.00
Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing. Qual Life Res (2011) 1.97
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96